Economic burden of antibiotic resistance in China: a national level estimate for inpatients

Table 6 Economic burden caused by inpatients with SDR and MDR infection or colonisation in China

Economic burden ($ billion)	SDR			MDR			ABR
Economic burden ($ billion)	Mean	95% UI		Mean	95% UI		Mean	95% UI
Direct economic burden
Direct medical cost	6	5	7	24	22	25	30	27	32
Direct non-medical cost	2	2	2	3	3	4	5	5	6
Direct economic burden	8	7	9	27	25	29	35	32	38
Indirect economic burden
Cost of productivity loss measured in DALYs	11	8	13	28	24	32	39	32	45
Cost of care giver	1	1	1	2	2	2	4	3	4
Indirect economic burden	12	9	15	30	26	34	42	35	49
Societal economic burden
Socio-economic burden	20	16	24	57	51	63	77	67	87
Socio-economic burden accounted for GDP (%)	0.10	0.08	0.11	0.27	0.25	0.30	0.37	0.32	0.42

SDR single-drug resistant, MDR multi-drug resistant, ABR antibiotic resistant, UI uncertainty interval, DALYs disability-adjusted life years, GDP gross domestic product

ISSN: 2047-2994